Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Top Electrophysiologists Assess AF Balloon Ablation Devices

This article was originally published in The Gray Sheet

Executive Summary

Atrial fibrillation balloon ablation devices could benefit from a fundamental design change, proposed leading AF ablation electrophysiologists at the Boston AF Symposium Jan. 14

You may also be interested in...



CryoCor Sees Opportunity With A-Fib Ablation Label; Do Physicians Agree?

CryoCor hopes its lead in the race to gain an atrial fibrillation indication for an ablation catheter will translate into a market advantage, but first it will need to change what it says are misperceptions among some physicians about the limitations of cryoenergy

CryoCor Sees Opportunity With A-Fib Ablation Label; Do Physicians Agree?

CryoCor hopes its lead in the race to gain an atrial fibrillation indication for an ablation catheter will translate into a market advantage, but first it will need to change what it says are misperceptions among some physicians about the limitations of cryoenergy

AF Ablation Lacks Evidence, Despite Growing Adoption – TEC Assessment

A recent BlueCross BlueShield Association assessment of atrial fibrillation ablation echoes widespread belief among payors and doctors that the technique is still evolving

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel